Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.91%110.85M | 14.45%113.27M | 12.79%105.27M | 5.71%380.87M | -1.49%96.32M | 13.21%102.72M | 11.17%98.97M | -0.22%93.33M | 15.63%360.32M | 63.68%97.78M |
| Cost of revenue | -13.67%75.46M | 15.45%72.06M | 20.89%68.77M | 10.82%277.26M | 0.17%70.55M | 46.20%87.41M | 7.86%62.41M | -8.41%56.89M | 24.58%250.19M | 54.43%70.43M |
| Gross profit | 131.05%35.39M | 12.73%41.21M | 0.16%36.5M | -5.91%103.62M | -5.77%25.77M | -50.51%15.32M | 17.31%36.56M | 15.98%36.44M | -0.58%110.12M | 93.51%27.35M |
| Operating expense | 121.98%9.43M | 28.33%11.84M | -5.48%9.99M | -348.67%-44.8M | -46.72%1.5M | -578.06%-42.9M | 2.44%9.23M | 48.84%10.57M | 189.78%18.02M | 106.44%2.82M |
| Selling and administrative expenses | -21.86%9.67M | 28.36%11.84M | -5.43%9.99M | 11.95%34.67M | -2.88%9.25M | 37.94%12.38M | 2.44%9.23M | 17.23%10.57M | 4,886.31%30.97M | 141.05%9.52M |
| -General and administrative expense | -21.86%9.67M | 28.36%11.84M | -5.43%9.99M | 11.95%34.67M | -2.88%9.25M | 37.94%12.38M | 2.44%9.23M | 17.23%10.57M | 4,886.31%30.97M | 141.05%9.52M |
| Depreciation and amortization | ---- | ---- | ---- | 4.32%4.86M | ---- | ---- | ---- | ---- | -10.33%4.65M | ---- |
| -Depreciation | ---- | ---- | ---- | 4.32%4.86M | ---- | ---- | ---- | ---- | -10.33%4.65M | ---- |
| Rent and land expenses | ---- | ---- | ---- | -21.09%101K | ---- | ---- | ---- | ---- | -3.03%128K | ---- |
| Other operating expenses | ---243K | ---3K | ---5K | 99.31%-5K | ---- | ---- | ---- | ---- | -421.68%-727K | ---- |
| Total other operating income | --0 | ---- | ---- | 396.50%84.42M | 15.59%7.74M | --55.28M | -79.03%1.08M | 30.72%2.5M | -35.19%17M | -64.08%6.7M |
| Operating profit | -55.41%25.96M | 7.46%29.37M | 2.47%26.52M | 61.14%148.42M | -1.06%24.27M | 164.92%58.22M | 23.35%27.33M | 6.38%25.88M | -29.60%92.11M | -57.68%24.53M |
| Net non-operating interest income (expenses) | 17.80%-2.81M | 29.91%-2.3M | 15.89%-2.91M | 11.83%-13.57M | 9.65%-3.97M | 9.78%-3.42M | 14.05%-3.29M | 21.43%-3.46M | 4.37%-15.39M | -6.50%-4.39M |
| Non-operating interest income | 12.27%622K | 72.80%1.1M | 12.05%660K | 8.14%2.6M | ---- | -3.82%554K | 26.95%636K | --589K | 6.64%2.41M | ---- |
| Non-operating interest expense | -13.61%3.43M | -13.26%3.4M | -11.83%3.57M | -9.12%16.18M | -9.65%3.97M | -9.00%3.98M | -9.30%3.92M | -8.06%4.05M | -3.01%17.8M | -9.10%4.39M |
| Net investment income | -7.89%245K | 270.11%444K | -71.94%259K | -108.77%-240K | -56.75%266K | -108.26%-261K | 923K | 20.53%2.74M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 131.48%125K | 75.82%160K | -5.65%117K | -41.30%415K | -71.43%54K | -56.87%91K | 124K | -61.24%707K | ||
| Income from associates and other participating interests | 33,234.48%29M | -887.38%-4.99M | -507.30%-6.99M | -12.50%-17.22M | -204.99%-16.79M | 107.19%87K | 114.63%634K | 72.97%-1.15M | 8.77%-15.31M | 17.92%-5.51M |
| Special income (charges) | -94.26%639K | 37.06%747K | 12.84%870K | -94.05%111K | 4,500.00%11.13M | -54.36%545K | 771K | -51.70%1.87M | ||
| Less:Impairment of capital assets | ---- | ---- | ---- | -50.00%1K | ---- | ---- | ---- | ---- | -96.88%2K | ---- |
| Less:Other special charges | 94.26%-639K | -37.06%-747K | -12.84%-870K | 94.00%-112K | ---- | -4,500.00%-11.13M | 54.36%-545K | ---771K | 52.43%-1.87M | ---- |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | -21.95%96K | 45.31%93K | 47.92%142K | 0.28%352K | -0.81%123K | -1.54%64K | 96K | -5.90%351K | ||
| Income before tax | -19.87%53.25M | -6.36%23.52M | -22.33%18M | 76.34%118.26M | -76.03%3.51M | 266.30%66.46M | 34.83%25.12M | 48.01%23.18M | -18.09%67.07M | -41.59%14.63M |
| Income tax | -72.04%5.28M | 14.99%6.41M | -12.58%5.1M | -10.69%15.73M | -373.45%-14.56M | 507.40%18.89M | 7.30%5.57M | 46.27%5.83M | 14.04%17.61M | 350.71%5.33M |
| Net income | 0.85%47.97M | -12.45%17.12M | -25.61%12.91M | 107.34%102.53M | 94.15%18.07M | 216.42%47.57M | 45.46%19.55M | 48.60%17.35M | -25.56%49.45M | -65.75%9.31M |
| Net income continuous operations | 0.85%47.97M | -12.45%17.12M | -25.61%12.91M | 107.34%102.53M | 94.15%18.07M | 216.42%47.57M | 45.46%19.55M | 48.60%17.35M | -25.56%49.45M | -65.75%9.31M |
| Noncontrolling interests | -87.35%2.95M | 43.23%3.67M | 3.06%2.4M | 292.43%29.4M | -56.51%1.2M | 1,464.77%23.32M | 56.57%2.56M | 43.81%2.32M | -33.65%7.49M | -55.48%2.75M |
| Net income attributable to the company | 85.63%45.02M | -20.85%13.45M | -30.04%10.51M | 74.29%73.14M | 157.29%16.87M | 79.08%24.25M | 43.92%16.99M | 49.37%15.03M | -23.90%41.96M | -68.77%6.56M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 85.63%45.02M | -20.85%13.45M | -30.04%10.51M | 74.29%73.14M | 157.29%16.87M | 79.08%24.25M | 43.92%16.99M | 49.37%15.03M | -23.90%41.96M | -68.77%6.56M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 85.83%0.0223 | -20.24%0.0067 | -30.67%0.0052 | 74.52%0.0363 | 162.50%0.0084 | 76.47%0.012 | 44.83%0.0084 | 50.00%0.0075 | -24.09%0.0208 | -69.52%0.0032 |
| Diluted earnings per share | 85.83%0.0223 | -20.24%0.0067 | -30.67%0.0052 | 74.52%0.0363 | 162.50%0.0084 | 76.47%0.012 | 44.83%0.0084 | 50.00%0.0075 | -24.09%0.0208 | -69.52%0.0032 |
| Dividend per share | -50.00%0.005 | -50.00%0.005 | -50.00%0.005 | -24.24%0.05 | 21.21%0.02 | -39.39%0.01 | -39.39%0.01 | -39.39%0.01 | 0.00%0.066 | 0.00%0.0165 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.